Accuray gets FDA nod for breast cancer treatment on Radixact

The Radixact system. [Image from Accuray]Accuray (Nasdaq:ARAY) announced that the FDA granted 510(k) clearance to its VitalHold breast package on the Radixact system.
The company also says it expects the treatment option to become available in Europe.
VitalHold facilitates deep inspiration…

Source: www.massdevice.com – Read more